US5057420A
(en)
*
|
1987-06-05 |
1991-10-15 |
Granada Biosciences, Inc. |
Bovine nuclear transplantation
|
IL86588A0
(en)
*
|
1987-06-05 |
1988-11-30 |
Granada Genetics Inc |
Bovine nuclear transplantation
|
US5633076A
(en)
*
|
1989-12-01 |
1997-05-27 |
Pharming Bv |
Method of producing a transgenic bovine or transgenic bovine embryo
|
US5453366A
(en)
*
|
1990-07-26 |
1995-09-26 |
Sims; Michele M. |
Method of cloning bovine embryos
|
US5096822A
(en)
*
|
1990-07-26 |
1992-03-17 |
W. R. Grace & Co.- Conn. |
Bovine embryo medium
|
US6515009B1
(en)
|
1991-09-27 |
2003-02-04 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US5811447A
(en)
*
|
1993-01-28 |
1998-09-22 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
PT620849E
(pt)
*
|
1992-01-07 |
2003-11-28 |
Elan Pharm Inc |
Modelos animais transgenicos para a doenca de alzheimer
|
NZ247062A
(en)
*
|
1992-03-04 |
1995-07-26 |
Grace W R & Co |
Method for bovine nuclear transfer
|
US6107543A
(en)
*
|
1992-08-20 |
2000-08-22 |
Infigen, Inc. |
Culture of totipotent embryonic inner cells mass cells and production of bovine animals
|
US6491938B2
(en)
|
1993-05-13 |
2002-12-10 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US5981568A
(en)
|
1993-01-28 |
1999-11-09 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US6663881B2
(en)
|
1993-01-28 |
2003-12-16 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US5480772A
(en)
*
|
1993-02-03 |
1996-01-02 |
Brandeis University |
In vitro activation of a nucleus
|
US6680199B1
(en)
|
1993-02-10 |
2004-01-20 |
Infigen, Inc. |
In vitro activation of mammalian oocytes
|
US5496720A
(en)
*
|
1993-02-10 |
1996-03-05 |
Susko-Parrish; Joan L. |
Parthenogenic oocyte activation
|
US20030083733A1
(en)
*
|
1997-10-10 |
2003-05-01 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US20020091433A1
(en)
*
|
1995-04-19 |
2002-07-11 |
Ni Ding |
Drug release coated stent
|
US6099562A
(en)
*
|
1996-06-13 |
2000-08-08 |
Schneider (Usa) Inc. |
Drug coating with topcoat
|
US5837313A
(en)
*
|
1995-04-19 |
1998-11-17 |
Schneider (Usa) Inc |
Drug release stent coating process
|
US6717031B2
(en)
|
1995-06-07 |
2004-04-06 |
Kate Dora Games |
Method for selecting a transgenic mouse model of alzheimer's disease
|
US5907080A
(en)
*
|
1995-11-30 |
1999-05-25 |
Nexia Biotechnologies, Inc. |
Method for development of transgenic dwarf goats
|
US20010047520A1
(en)
*
|
1996-03-04 |
2001-11-29 |
Susko-Parrish Joan L. |
Parthenogenic oocyte activation
|
US7696404B2
(en)
*
|
1996-08-19 |
2010-04-13 |
Advanced Cell Technology, Inc. |
Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions
|
US20090092588A1
(en)
*
|
1997-01-10 |
2009-04-09 |
University Of Massachusetts As Represented By Its Amherst Campus |
Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including parkinson's disease
|
US6235969B1
(en)
*
|
1997-01-10 |
2001-05-22 |
University Of Massachusetts |
Cloning pigs using donor nuclei from non-quiescent differentiated cells
|
US5945577A
(en)
*
|
1997-01-10 |
1999-08-31 |
University Of Massachusetts As Represented By Its Amherst Campus |
Cloning using donor nuclei from proliferating somatic cells
|
US6215041B1
(en)
*
|
1997-01-10 |
2001-04-10 |
University Of Mmassachusetts |
Cloning using donor nuclei from a non-quiesecent somatic cells
|
US6011197A
(en)
|
1997-03-06 |
2000-01-04 |
Infigen, Inc. |
Method of cloning bovines using reprogrammed non-embryonic bovine cells
|
US6331659B1
(en)
|
1998-01-21 |
2001-12-18 |
University Of Hawaii |
Cumulus cells as nuclear donors
|
US6700037B2
(en)
|
1998-11-24 |
2004-03-02 |
Infigen, Inc. |
Method of cloning porcine animals
|
US6258998B1
(en)
|
1998-11-24 |
2001-07-10 |
Infigen, Inc. |
Method of cloning porcine animals
|
SE9902817D0
(sv)
*
|
1999-07-30 |
1999-07-30 |
A & Science Invest Ab |
A method for selective electrofusion of at least two fusion partners having cell-like membranes
|
US6383813B1
(en)
|
1999-09-14 |
2002-05-07 |
Cornell Research Foundation, Inc. |
Microfabrication of a nuclear transfer array for high-throughput animal cloning
|
WO2001035735A1
(fr)
*
|
1999-11-19 |
2001-05-25 |
Hematech, Llc |
Production d'ongules, de preference des bovins, qui produisent des immunoglobulines humaines
|
US7820878B2
(en)
*
|
1999-11-19 |
2010-10-26 |
Kyowa Hakko Kirin Co., Ltd. |
Production of ungulates, preferably bovines that produce human immunoglobulins
|
US7414170B2
(en)
*
|
1999-11-19 |
2008-08-19 |
Kirin Beer Kabushiki Kaisha |
Transgenic bovines capable of human antibody production
|
US7074983B2
(en)
|
1999-11-19 |
2006-07-11 |
Kirin Beer Kabushiki Kaisha |
Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin
|
ATE517990T1
(de)
|
2000-03-15 |
2011-08-15 |
Univ Georgia |
Effektive kernumprogrammierung in säugetieren
|
EA013564B1
(ru)
*
|
2000-08-03 |
2010-06-30 |
Терапеутик Хьюман Поликлоналз Инк. |
Гуманизированный иммуноглобулин и содержащая его фармацевтическая композиция
|
US6677500B2
(en)
*
|
2000-08-15 |
2004-01-13 |
Board Of Trustees Of The University Of Illinois |
Ungulates expressing exogenous IGF-I in their milk
|
US20040029825A1
(en)
*
|
2001-10-03 |
2004-02-12 |
Davies Christopher J |
Methods of minimizing immunological rejection of a nuclear transfer fetus
|
US20030027331A1
(en)
*
|
2000-11-30 |
2003-02-06 |
Yan Wen Liang |
Isolated homozygous stem cells, differentiated cells derived therefrom, and materials and methods for making and using same
|
EP1356035B1
(fr)
|
2000-12-22 |
2011-03-16 |
Kyowa Hakko Kirin Co., Ltd. |
Methodes de clonage de mammiferes non humains a l'aide de chromatine donneuse reprogrammee ou de cellules donneuses reprogrammees
|
US7491534B2
(en)
*
|
2000-12-22 |
2009-02-17 |
Kirin Holdings Kabushiki Kaisha |
Methods for altering cell fate to generate T-cells specific for an antigen of interest
|
US20020142397A1
(en)
*
|
2000-12-22 |
2002-10-03 |
Philippe Collas |
Methods for altering cell fate
|
JP4223284B2
(ja)
*
|
2001-01-02 |
2009-02-12 |
ステムロン インコーポレイテッド |
予め選抜されたイムノタイプおよび/またはジェノタイプを有するホモ接合性幹細胞群の製造方法、該細胞由来の移植に適切な細胞、並びにこれらを用いた材料および方法
|
AUPR446701A0
(en)
*
|
2001-04-18 |
2001-05-17 |
Gene Stream Pty Ltd |
Transgenic mammals for pharmacological and toxicological studies
|
US6613083B2
(en)
*
|
2001-05-02 |
2003-09-02 |
Eckhard Alt |
Stent device and method
|
US20030113910A1
(en)
*
|
2001-12-18 |
2003-06-19 |
Mike Levanduski |
Pluripotent stem cells derived without the use of embryos or fetal tissue
|
US20040133931A1
(en)
*
|
2003-01-08 |
2004-07-08 |
Gavin William G. |
Method and system for fusion and activation following nuclear transfer in reconstructed embryos
|
US20030229909A1
(en)
*
|
2002-02-13 |
2003-12-11 |
The Texas A&M University System |
Cloning cats by nuclear transplantation
|
EP1490487A4
(fr)
*
|
2002-04-01 |
2007-08-29 |
Gtc Biotherapeutics Inc |
Procede permettant la selection de lignees cellulaires convenant pour le transfert de noyau chez les especes mammiferes
|
US7371922B2
(en)
*
|
2002-07-31 |
2008-05-13 |
The Board Of Trustees Of The University Of Illinois |
Nuclear transfer with porcine embryonic stem cells
|
AU2003257155A1
(en)
*
|
2002-08-02 |
2004-02-23 |
The General Hospital Corporation |
Methods for the production of cells and mammals with desired genetic modifications
|
EP1544286A4
(fr)
*
|
2002-08-08 |
2007-06-27 |
Univ Tokyo Nat Univ Corp |
Robot pouvant mettre en oeuvre des operations sur une cellule unique
|
DE60330468D1
(de)
|
2002-08-21 |
2010-01-21 |
Revivicor Inc |
Schweine ohne jegliche expression funktioneller alpha-1,3-galactosyltransferase
|
US8106251B2
(en)
|
2002-08-21 |
2012-01-31 |
Revivicor, Inc. |
Tissue products derived from porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase
|
US20040077077A1
(en)
*
|
2002-10-18 |
2004-04-22 |
Xiangzhong Yang |
Novel methods for the production of cloned mammals, mammals cloned according to the methods, and methods of use of same
|
KR20050093761A
(ko)
|
2002-11-08 |
2005-09-23 |
헤마테크, 엘엘씨 |
프리온 단백질 활성이 감소된 트랜스제닉 유제동물 및 그의용도
|
WO2004053090A2
(fr)
*
|
2002-12-10 |
2004-06-24 |
Gtc Biotherapeutics, Inc. |
Procede et systeme d'utilisation d'embryons de transfert nucleaire cellulaire de cellule somatique en tant que donneurs de cellules pour un transfert nucleaire supplementaire
|
WO2005037191A2
(fr)
*
|
2003-09-15 |
2005-04-28 |
Gtc Biotherapeutics, Inc. |
Expression de recepteurs transmembranaires negatifs dominants dans le lait d'animaux transgeniques
|
NZ550106A
(en)
*
|
2004-04-22 |
2009-06-26 |
Kyowa Hakko Kirin Co Ltd |
Transgenic animals and uses thereof
|
NZ554824A
(en)
|
2004-10-22 |
2010-10-29 |
Revivicor Inc |
Porcines that lack endogenous antibody chains and express exogenous immunoglobulins
|
KR100733012B1
(ko)
|
2005-07-26 |
2007-06-28 |
재단법인서울대학교산학협력재단 |
복제된 개과 동물 및 이의 생산 방법
|
ES2836764T3
(es)
|
2005-08-03 |
2021-06-28 |
Astellas Inst For Regenerative Medicine |
Métodos mejorados de reprogramación de células somáticas animales
|
EP1924686A4
(fr)
|
2005-08-09 |
2009-11-11 |
Revivicor Inc |
Ongules transgéniques exprimant la ctla4-ig et leurs utilisations
|
CN100357435C
(zh)
*
|
2006-01-13 |
2007-12-26 |
山东大学 |
一种细胞核移植的方法
|
JP5087625B2
(ja)
|
2006-09-01 |
2012-12-05 |
セラピューティック・ヒューマン・ポリクローナルズ・インコーポレーテッド |
非ヒトトランスジェニック動物におけるヒトまたはヒト化免疫グロブリンの発現強化
|
KR100829426B1
(ko)
*
|
2007-01-17 |
2008-05-15 |
재단법인서울대학교산학협력재단 |
복제개의 생산 방법
|
CA2679109C
(fr)
|
2007-02-23 |
2016-07-19 |
Advanced Cell Technology, Inc. |
Derivation de cellules souches embryonnaires
|
KR100868245B1
(ko)
*
|
2007-05-29 |
2008-11-11 |
강원대학교산학협력단 |
데메콜친 처리에 의한 효율적인 복제 동물의 생산방법
|
CN101668847A
(zh)
*
|
2007-11-19 |
2010-03-10 |
财团法人首尔大学校产学协力财团 |
用于体细胞核移植的犬科出生率的提高方法
|
JP2011508600A
(ja)
|
2008-01-04 |
2011-03-17 |
ソウル ナショナル ユニバーシティ インダストリー ファウンデーション |
形質転換された複製犬の生産方法
|
EP2348827B1
(fr)
|
2008-10-27 |
2015-07-01 |
Revivicor, Inc. |
Ongulés immunodéprimés
|
WO2012112586A1
(fr)
|
2011-02-14 |
2012-08-23 |
Revivicor, Inc. |
Cochons génétiquement modifiés destinés à la xénotransplantation de xénogreffes vascularisées et de dérivés de celles-ci
|
WO2015081182A1
(fr)
|
2013-11-27 |
2015-06-04 |
The Curators Of The University Of Missouri |
Activation artificielle d'oocyte
|
KR102617137B1
(ko)
|
2014-09-15 |
2023-12-27 |
칠드런'즈 메디컬 센터 코포레이션 |
히스톤 h3-리신 트리메틸화를 제거함으로써 체세포 핵 이식(scnt) 효율을 증가시키는 방법 및 조성물
|
CA3096274A1
(fr)
|
2018-04-06 |
2019-10-10 |
Children's Medical Center Corporation |
Compositions et procedes de reprogrammation de cellules somatiques et de modulation d'impression
|
EP4247151A1
(fr)
|
2020-11-20 |
2023-09-27 |
Revivicor Inc. |
Porcs multitransgéniques présentant une inactivation du récepteur de l'hormone de croissance pour une xénogreffe
|
CA3232376A1
(fr)
|
2021-09-20 |
2023-03-23 |
Maria KOKKINAKI |
Porcs sceniques multitran comprenant dix modifications genetiques pour une xenogreffe
|